Needle revision outcomes after glaucoma filtering surgery: survival analysis and predictive factors

摘要

Purpose: To evaluate the efficacy and safety of needle revision and examine factors predictive of failure. Methods: In total, 157 eyes of 131 patients that underwent needle revision augmented with either 5-fluorouracil or betamethasone for trabeculectomy failure were included in this retrospective study. Complete failure was defined as additional glaucoma surgery, ciliodestructive procedures, loss of light perception, sight-threatening complications, hypotony maculopathy, and surgical bleb revision. Success was defined as intraocular pressure???18 (criterion A), ?15 (criterion B), and ?12?mmHg (criterion C) reached with (qualified) or without (complete) medications, and absence of any criteria of complete failure. Results: The median (interquartile range) follow-up was 25.0 (41.0) months. Complete failure rates were 19%, 26%, and 31% at 1, 2, and 3?years, respectively. For criterion A, qualified and complete success rates were, respectively, 77% and 69% at 1?year, 66% and 51% at 2?years, and 60% and 47% at 3?years. For criterion B, qualified and complete success rates were, respectively, 67% and 61% at 1?year, 48% and 42% at 2?years, and 44% and 39% at 3?years. For criterion C, qualified and complete success rates were, respectively, 43% and 41% at 1?year, 27% and 25% at 2?years, and 24% and 23% at 3?years. High baseline intraocular pressure and primary surgery were associated with higher and lower risks of complete failure, respectively. Conclusion: Needle revision is an effective and safe procedure to rescue failing trabeculectomy postponing or avoiding further glaucoma surgery. Eyes with low target intraocular pressure may have poor long-term outcomes.